HeartSciences (HSCS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Jun, 2026Executive summary
HeartSciences and Fortitude Mining Holdings entered into a definitive merger agreement, with the combined company to operate under the Fortitude brand and trade on Nasdaq as "TUDE" after closing in H2 2026.
Fortitude is a leading Zcash mining platform, currently wholly-owned by DCG, with vertically integrated operations and a focus on high-conviction Proof-of-Work digital assets.
The transaction is structured as an all-stock merger, with DCG expected to own approximately 95% of the combined company at closing.
The combined company aims to leverage Fortitude's mining expertise and HeartSciences' AI-enabled ECG technology, with HeartSciences' CEO leading the healthcare business unit post-merger.
The merger is subject to customary closing conditions, including shareholder approval and regulatory clearance.
Voting matters and shareholder proposals
Shareholders will vote on the issuance of new classes of stock, approval of the merger agreement, adoption of a new charter, and amendment of the equity incentive plan.
Support agreements have been executed by key shareholders to vote in favor of the merger and related proposals.
The board recommends approval of all proposals and will solicit proxies accordingly.
Board of directors and corporate governance
Post-merger, the board will be expanded and reconstituted with individuals designated by Fortitude's seller, with two current HeartSciences directors remaining.
Andrea Childs will become CEO and Erik Ellingson CFO of the combined company.
The amended LLC agreement will establish HeartSciences as the sole managing member of the surviving company.
Latest events from HeartSciences
- Fortitude and HeartSciences announce an all-stock merger, targeting completion in late 2026.HSCS
Proxy filing24 Jun 2026 - HeartSciences and Fortitude will merge to create a public Zcash mining leader, targeting H2 2026 close.HSCS
Proxy filing23 Jun 2026 - Vertically integrated Zcash miner leverages scale, DCG backing, and operational discipline for growth.HSCS
Investor presentation23 Jun 2026 - Expanded AI-ECG offerings, strong balance sheet, and regulatory progress set stage for growth.HSCS
Q4 20248 Jun 2026 - Net loss increased to $2.1 million as R&D costs rose and new financing was secured.HSCS
Q1 20258 Jun 2026 - AI-ECG platform advances, FDA submission nears, CMS reimbursement secured, no revenue, $4.1M cash.HSCS
Q2 20258 Jun 2026 - Net loss increased, cash reserves fell, and continued operations depend on new funding and FDA clearance.HSCS
Q3 20258 Jun 2026 - AI-ECG platform launch and regulatory progress set stage for 2026 commercialization.HSCS
Q4 20258 Jun 2026 - FDA breakthrough, new AI-ECG platform launch, and urgent capital needs amid ongoing losses.HSCS
Q1 20268 Jun 2026